• Health & Medicine
• Policy & Insight

England’s cancer strategy: what has changed in the last two years?

Progress has been made against England's cancer strategy, including investment for radiotherapy. But more needs to be done to support the NHS workforce. Progress has been made against England's cancer strategy, including investment for radiotherapy. But more needs to be done to support the NHS workforce.

19 October 2017

• Health & Medicine
• Policy & Insight

Brexit will have large impact on health and NHS, say researchers

Leaving the EU brings large risks but also opportunities for health and the NHS, according to a new study. Leaving the EU brings large risks but also opportunities for health and the NHS, according to a new study.

29 September 2017

• Health & Medicine

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care. A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

31 August 2017

• Health & Medicine

Early detection of cancer highlighted in new life sciences industrial strategy

Early detection of cancer could be vastly improved by seizing opportunities in the UK’s life sciences, according to a new report. Early detection of cancer could be vastly improved by seizing opportunities in the UK’s life sciences, according to a new report.

30 August 2017

• Health & Medicine

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer. The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

16 June 2017

• Policy & Insight

General Election 2017: What are the political parties promising for cancer and research?

A week away from the general election, we’ve put some of the manifestos under the microscope to see what they mean for cancer, research and patients. A week away from the general election, we’ve put some of the manifestos under the microscope to see what they mean for cancer, research and patients.

2 June 2017

• Health & Medicine

General Election 2017: 4 things we want political parties to focus on

We look at the most important areas that parties need to focus on to tackle cancer ahead of the General Election. We look at the most important areas that parties need to focus on to tackle cancer ahead of the General Election.

28 April 2017

• Health & Medicine

NHS England sets target of 5,000 more people each year surviving cancer

NHS England aims for an extra 5,000 people each year to survive cancer by 2019, a new report claims. NHS England aims for an extra 5,000 people each year to survive cancer by 2019, a new report claims.

31 March 2017

• Health & Medicine

'Unacceptable' plans revealed by NICE that could delay availability of drugs on the NHS in England

Plans to create an additional affordability test for medicines available on the NHS have been labelled ‘unacceptable’ by charities and politicians. Plans to create an additional affordability test for medicines available on the NHS have been labelled ‘unacceptable’ by charities and politicians.

15 March 2017

• Science & Technology
• Health & Medicine

Budget 2017: Investment in social care and training young scientists

Additional funding for social care and investment in new research training placements have been announced in the Spring Budget. Additional funding for social care and investment in new research training placements have been announced in the Spring Budget.

9 March 2017

• Health & Medicine

A one-off bowel scope helps prevent bowel cancer, but it’s taking time to reach everyone eligible

A one-off screening test can cut bowel cancer risk for at least 17 years. A one-off screening test can cut bowel cancer risk for at least 17 years.

22 February 2017

• Health & Medicine

NHS cancer treatment target in England missed for third consecutive year

The ’62 day’ waiting time target for cancer patients in England has been missed again, marking 3 years since the target was last met. The ’62 day’ waiting time target for cancer patients in England has been missed again, marking 3 years since the target was last met.

9 February 2017